Replies to post #243648 on Elite Pharmaceuticals Inc (ELTP)

[namtae]

Sequest REJECTED by the FDA, they're now at Defcon 1!!

Best case scenario, approval mid 2018 when its already too late

Worse case scenario, no chance of approval and Elite comes clean with shareholders driving share price to .02

Likely scenario, Elite tries to keep the Sequest farce alive by conducting more expensive R&D, filings with the FDA in order to sucker investors into supporting its stock so theres somewhat of a market to absorb the 100's of millions more shares Elite will be unloading onto the market, via LP or other conduit